Biocept nabs three new patents covering cancer cell detection technology
Biocept (BIOC-5.5%) announces the award of three patents, one each in the U.S., Canada and Europe, covering its antibody and microchannel technology and enhanced detection of cancer cells.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.